Cannasouth - Latest News [Page 1]

First Medicinal Cannabis Products Will Deliver Wider Treatment Options To Patients

Thursday, 19 May 2022, 1:05 pm | Cannasouth

Successful assessment by the Medicinal Cannabis Agency of Cannasouth’s first medicinal cannabis products will deliver wider treatment options to New Zealand patients and prescribers. Cannasouth has had three products successfully assessed by the Government’s ... More >>

Cannasouth Opens $6 Million Capital Raising To Fund Revenue-generating Growth Phase

Friday, 16 July 2021, 9:51 am | Cannasouth

Medicinal cannabis company, Cannasouth Limited (NZX:CBD), announced this morning that it has opened a $6 million offer to consolidate its operations to take full advantage of the revenue opportunities ahead of it. Earlier this month, Cannasouth ... More >>

Cannasouth To Buy Out Cultivation And Manufacturing Joint Venture Partners

Monday, 5 July 2021, 9:58 am | Cannasouth

Leading medicinal cannabis company, Cannasouth Limited has today entered into two conditional agreements to acquire the balance of the stakes that it does not already own in its cultivation and manufacturing joint venture businesses. Acquisition of ... More >>

Cannasouth Commissions Growing Facility As It Gears Up For International Exports

Monday, 28 June 2021, 12:38 pm | Cannasouth

NZX listed medicinal cannabis company Cannasouth expects to be ready to export pharmaceutical grade cannabis flower in early 2022 after completing commissioning of its Waikato-based growing facility. Cannasouth’s joint venture partner, Cannasouth Cultivation Limited, ... More >>

Cannasouth Joins Forces With Leading US Cultivation Company

Tuesday, 21 July 2020, 6:51 pm | Cannasouth

Through its joint venture subsidiary, Cannasouth Cultivation Limited (CCL), Cannasouth Limited has entered into a service agreement with EAH Enterprises LLC, trading as Vera Cultivation in Colorado, USA. Vera Cultivation (Vera) is a US market leader ... More >>

Experienced Healthcare Marketer Joins Cannasouth To Lead First Products To Market

Tuesday, 21 July 2020, 6:49 pm | Cannasouth

NZX listed medicinal cannabis company, Cannasouth Limited has appointed experienced healthcare sales and marketing executive John Sanders as Chief Commercial Officer. Sanders will be responsible for developing and implementing marketing and sales strategies ... More >>

Cannasouth Raises More Than $6m In New Capital

Monday, 4 May 2020, 10:53 am | Cannasouth

Cannasouth’s recently closed Share Purchase Plan (SPP) has raised a total of $5,690,014 through the issue of 14,973,721 new ordinary fully paid shares. The SPP has not been scaled. Cannasouth received excess acceptances of $690,014 under the SPP, and the ... More >>

Cannasouth Announces Share Purchase Plan

Wednesday, 15 April 2020, 9:04 am | Cannasouth

Cannasouth has today announced an offer of existing ordinary shares to raise NZ$3 million pursuant to a Share Purchase Plan (SPP) to existing shareholders to accelerate development of the Company’s key initiatives following the commencement of the ... More >>

Cannasouth appoints experienced new CFO

Thursday, 23 January 2020, 12:52 pm | Cannasouth

New Zealand’s only NZX listed medicinal cannabis company Cannasouth has appointed Colin Foster as the company’s new Chief Financial Officer. More >>

Cannasouth secures consent for new cultivation facility

Monday, 23 December 2019, 1:11 pm | Cannasouth

Cannasouth’s joint venture partner Cannasouth Cultivation Limited has received resource consent for construction of its world-class medicinal cannabis cultivation facility in the Waikato. More >>

Cannasouth expands with 60% stake in Midwest Pharmaceutics

Tuesday, 1 October 2019, 11:13 am | Cannasouth

Leading medicinal cannabis company, Cannasouth Limited (NZX: CBD) (“Cannasouth” or “the Company”) is pleased to announce it has today entered into an agreement to acquire a 60 per cent shareholding in Hawkes Bay-based Midwest Pharmaceutics NZ ... More >>

Cannasouth welcomes new shareholders

Friday, 6 September 2019, 10:44 am | Cannasouth

Cannasouth has welcomed more than 550 new shareholders onto its share register since listing on the Main Board of the New Zealand Stock Exchange on June 19 this year. More >>

Cannasouth harvests 1st crop of medicinal research cannabis

Friday, 16 August 2019, 8:12 am | Cannasouth

Cannasouth has harvested its first crop of medicinal research cannabis from its purpose-built growing facility in Hamilton. More >>

Cannasouth announces cannabis cultivation venture

Wednesday, 14 August 2019, 1:00 pm | Cannasouth

Cannasouth today announced a long-term strategic joint venture (JV) with Aaron Craig and his family (Craig Family Interests) to construct and develop a world-class cannabis cultivation facility in the Waikato. More >>

Cannasouth favours prescription of medicinal cannabis by GPs

Thursday, 8 August 2019, 11:55 am | Cannasouth

Cannasouth has made its submission to the Ministry of Health (MOH) on the Government’s proposals for medicinal cannabis regulations to support the Medicinal Cannabis Scheme. More >>

MOH releases proposals for Medicinal Cannabis regulations

Wednesday, 10 July 2019, 2:14 pm | Cannasouth

Cannasouth today welcomed the release of the Ministry of Health’s (MOH) proposals for the medicinal cannabis regulations to support the Medicinal Cannabis Scheme. More >>

Noted scientist David Gill joins Cannasouth

Monday, 8 July 2019, 10:26 am | Cannasouth

Cannasouth has appointed David Gill as Product Development Manager, who will take responsibility for bringing the company’s first medicinal cannabis products to the market. More >>

Cannasouth secures R&D funding from Callaghan Innovation

Wednesday, 3 July 2019, 3:20 pm | Cannasouth

The Board of Cannasouth Limited (NZX: CBD) is pleased to advise it has received confirmation of funding from Callaghan Innovation to support two of its medicinal cannabis research programmes, subject to completion of the formal contract. More >>

Medicinal cannabis research company intends to list on NZX

Tuesday, 23 October 2018, 11:41 am | Cannasouth

In a first for New Zealand, medicinal cannabis research company Cannasouth has announced it will make an application to list its shares on the NZX Main Board through an initial public offering (IPO) during the second calendar quarter of 2019. More >>